- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines (24h)
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Sequenom Inc. | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
SEQUENOM INC
Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds.
|
|
| Symbol: |
SQNM |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
47,140
|
41,000
|
28,490
|
34.39
|
|
Earnings before Interest & Tax ($000)
|
-43,810
|
-21,970
|
-18,170
|
N/A
|
|
Profit/Loss ($000)
|
-44,150
|
-21,980
|
-17,570
|
N/A
|
|
Earnings per Share
|
-0.83
|
-0.54
|
-0.71
|
N/A
|
|
Total Assets ($000)
|
140,480
|
76,040
|
39,880
|
79.16
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
-51.80
|
-55.15
|
-94.49
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
47,150
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
-44,150
|
N/A
|
|
Earnings per Share
|
N/A
|
-0.83
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
61,250,000
|
60,680,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Harry Stylli, Presi.; C.E.O. |
| |
| Contact Information |
| Address: |
3595 John Hopkins Court,
San Diego,
CA,
92121 |
Phone: |
858-202-9000 |
| Fax: |
858-202-9001 |
| Web Address: |
www.sequenom.com |
| E-Mail : |
acaterina@sequenom.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
SQNM-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
